TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Haemonetics Corporation (HAE)

Healthcare Medical Devices
86.80 $
+1.5% vs. previous close
Closing price · As of: 3. Aug 2026

Haemonetics Corporation (HAE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Revenue" came in at 1,334 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Income Statement HAE
Tick rows to compare them in a chart (up to 4) 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
910 909 886 904 968 988 870 993 1,169 1,309 1,361 1,334
476 503 508 492 550 501 442 462 546 597 582 590
434 406 378 412 418 488 428 531 623 712 779 744
54 56 47 39 36 39 41 55 59 63 69 60
259 313 299 313 294 262 261 328 367 414 414 442
394 450 398 356 334 384 339 450 467 547 557 502
41 -44 -19 56 84 103 90 81 156 165 222 241
9.4 9.5 8.1 4.5 9.9 16 17 17 15 13 9.7 29
31 -53 -27 60 74 87 73 64 141 152 212 128
14 2.2 -1.2 14 19 11 -6.6 20 26 34 44 31
17 -56 -26 46 55 77 79 43 115 118 168 97
127 129 123 153 193 258 184 192 252 295 356 312

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?